Fed Circuit rejects Stanford Uni’s ‘abstract’ genetics patent
15-03-2021
CareDx drops transplant testing patent suit
03-09-2020
Natera sues ArcherDX for oncology patent infringement
29-01-2020
jejim / Shutterstock.com
Stanford University has accused genetic testing company Natera of infringing two patents that cover a non-invasive method of testing if transplanted organs are being rejected.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Stanford University, CareDx, molecular diagnostics, Natera, patent infringement, blood tests, DNA
